Hongyuan Ding 1, Yi Zhu 2, Han Wu 3, Ling Zhang 1, Yaxin Gao 4, Qian Zhong 4, Qiumin Zhou 2, Ming Qi 1, Long Qian 5, Weiqiang Dou5, and Tong Wang2
1Radiology department, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, 2Rehabilitation Department, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, 3Rehabilitation Department, Nanjing Drum Tower Hospital, The Affiliated Hospital of the Medical School at Nanjing University, Nanjing, China, 4Nanjing Medical University, Nanjing, China, 5MR Research China, GE Healthcare, Beijing, China
Synopsis
In
this study, the whole brain cerebral
blood perfusion (CBF) values have been respectively investigated for patients
with subjective cognitive
decline (SCD) and mild cognitive impairment (MCI) and healthy controls
(HCs). Significantly lower CBF
values for the left superior frontal gyrus, left middle frontal gyrus, and left
caudate nucleus regions have been shown in SCD patients than HCs. Additionally,
the CBFs at these regions also showed strong correlations with multiple
clinical scales. Therefore, CBF can be considered an effective tool in the
early detection of SCD patients.
Introduction
Subjective
cognitive decline (SCD) and mild cognitive impairment (MCI) are considered as
two continuous stages from normal cognition progressing to Alzheimer's Disease (AD)1,2.
So far, many MRI studies have found reduced regional cerebral blood flow (CBF)
in patients with AD3,4. Meanwhile, some others have reported the
elevated index of regional cerebrovascular resistance in brain sub-regions of
subcortical, medial temporal, posterior cingulate, precuneus, inferior parietal
and superior temporal in AD patients, and of subcortical and posterior
cingulate in MCI patients5.
However,
changes in resting-state CBF and the correlations between CBF and cognitive
evaluations in SCD remain unknown. To investigate this, region-specific CBF
values were correspondingly calculated in patients with SCD and MCI as well as
health controls (HCs), and then compared among three groups. In addition, the
correlations between the region-specific CBF values of all subjects and
multiple clinical scales were estimated, respectively.Materials and Methods
Subjects
Thirty-two
patients, of which eighteen patients (mean: 70.01±6.9years)
were clinically confirmed with SCD and the rest fourteen (mean: 69.6±6.3years) were diagnosed
with MCI, have been recruited in this study. For comparison, twenty-one HCs
(mean: 73.5±5.9years)
were also included.
Each subject involved was assessed
with multiple clinical scales, including Mini-Mental-State-Examination (MMSE),
Montreal-Cognitive-Assessment, Wechsler-Memory-Scale-Revised-logical-memory-Test,
Trail-Making-Test (TMT) A&B, Auditory-Verbal-Learning-Test (AVLT), Boston-Naming-Test,
Functional-Activities-Questionnaire, Short-Form-Health-Survey
and Geriatric-Depression-Scale.
High
resolution T1-weighted (T1w) MR anatomical brain images and 3D arterial-spin-labeling
(3D-ASL) images have been acquired for each subject.
MRI
experiment
All
MR experiments were performed at a 3T-MR scanner (Discovery 750W, GE
Healthcare, USA) equipped with a 24-channel head coil.
A
fast-spoiled-gradient-echo based 3D-BRAVO sequence was employed to acquire 1mm3-isotropic
T1w MR images. The scan parameters were of field-of-view (FOV)= 256x256mm2,
repetition time (TR)=8.5ms, echo time (TE)=3.2ms, inversion time (TI)=450ms,
flip angle (FA)=12degree, number of slices=192, slice thickness=1mm, matrix
size=256x256 and bandwidth=31.25kHz.
For
cerebral perfusion measurement, a fast-spin-echo based 3D pseudo-continuous ASL
technique was used. The scan parameters included TR=4640ms, TE=10.7ms, FOV=
240x240mm2, slice thickness=4mm, number of slices=36, 512 sampling points on eight spiral
arms
and post-label delay=1525ms.
Total
scan time was less than 18 minutes.
Data analysis
The
CBF images were obtained using a vendor-provided ASL software in the ADW4.6 workstation
(GE Healthcare). To extract the atlas based CBF values, T1w anatomical images
of each subjects were first co-registered to CBF images. Then, the
co-registered T1w images were normalized to MNI space using SPM12. Thereafter,
all the CBF images could be transformed to MNI space. Lastly, the Automated
Anatomical Labeling (AAL) atlas was applied to all the normalized CBF images to
extract the values of the former 90 regions.
All
statistical analyses were performed in SPSS software 20.0. One way analysis-of-variance (ANOVA)
with the factor of group and subsequent post-hoc-t tests were applied to detect
the difference of region-specific CBF values among SCD, MCl patients and
HCs. The effects of age, gender and years of education were adjusted for all of
these analyses. In addition, Pearson correlation analysis was separately employed
to evaluate the relationship between the region-specific CBF values for all
subjects and each of clinical scale scores. Significance threshold was set as
p<0.05.Results
With
one way ANOVA analysis, a main effect of group in the investigation of
between-group variation of CBF values was revealed, respectively, at the left
superior frontal gyrus (F(2,52)=3.66,
p=0.033), left middle frontal gyrus (F(2,52)=4.03, p=0.024) and left
caudate nucleus regions (F(2,52)=4.87, p=0.012). The corresponding post-hoc-t
test further indicated that the CBF values in SCD group were significantly
lower than those in HC group (Fig.1) for left superior frontal gyrus (mean:
46.9±9.1 vs 52.2±13.2 ml/100g/min; p=0.028), left
middle frontal gyrus (mean: 44.9±8.3 vs 49.5±14.7 ml/100g/min; p=0.031) and left caudate nucleus regions
(mean: 36.7±6.4 vs 41.2±7.0 ml/100g/min; p<0.001).
Using
Pearson correlation analysis, the CBFs of left superior frontal gyrus (Table.1)
and left middle frontal gyrus (Table.2) regions showed significant
positive correlations with each of AVLT-immediate recall (2&3), AVLT-short recall, AVLT-delayed recall
and AVLT-recognition score, respectively (all p<0.05). Meanwhile, a
significant negative correlation was revealed between the CBF values at left
middle frontal gyrus and TMT-A (p<0.05; Table.2). Additionally, the CBF values of the
left caudate nucleus (Table.3) showed a significant positive correlation with AVLT including AVLT-immediate
recall (2&3), AVLT-long delayed recall, AVLT-recognition score and MMSE.Discussion and conclusion
In this study, we systematically
investigated the CBF values among patients with SCD, MCI and HCs. Significantly
lower CBF values for the left superior frontal gyrus, left middle frontal
gyrus, and left caudate nucleus regions have been shown in SCD patients than
HCs, indicating that early changes of CBF could be an important biomarker in SCD
individuals.
Additionally, strong correlations were
respectively revealed between the CBF values of the left superior frontal
gyrus, left middle frontal gyrus and left caudate nucleus with multiple
clinical scales. We can thus infer that in the early stage of cognitive
decline, reduced CBF in left prefrontal cortex and left caudate nucleus might
be the cause of the drop of AVLT scores and TMT-A. Because prefrontal cortex is
involved in memory storage, retrieval and executive function (especially
working memory and response selection), while the caudate nucleus is involved
in reinforcement learning6.
In
conclusion, the CBF might be considered an effective biomarker in the early
detection of SCD patients.Acknowledgements
No acknowledgement found.References
1.Cheng YW, Chen TF, Chiu MJ.
From mild cognitive impairment to subjective cognitive decline: conceptual and
methodological evolution. Neuropsychiatr Dis Treat 2017;13:491-8.
2.Rabin LA, Smart CM,
Amariglio RE. Subjective Cognitive Decline in Preclinical Alzheimer's
Disease. Annu Rev Clin Psychol 2017;13:369-96.
3. de Eulate R,
Goñi I, Galiano A et al. Reduced Cerebral Blood Flow in Mild
Cognitive Impairment Assessed Using Phase-Contrast MRI. J. Alzheimers Dis.
2017;58:585-95.
4. Leijenaar JF, van
Maurik IS, Kuijer JPA et al. Lower cerebral blood flow in
subjects with Alzheimer's dementia, mild cognitive impairment, and subjective
cognitive decline using two-dimensional phase-contrast magnetic resonance
imaging. Alzheimers Dement (Amst)
2017;9:76-83.
5.Nation DA, Wierenga CE, Clark LR et
al. Cortical and subcortical cerebrovascular resistance index in mild
cognitive impairment and Alzheimer's disease. J. Alzheimers Dis. 2013;36:689-98.
6. Gazzaniga
MS, Ivry RB, and Mangun GR. Cognitive Neuroscience: The Biology of the Mind (Forth
edition). W.W.Norton & Company, Inc. 2014. New York.